Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Gilead Sciences, Inc. > Profile

Instuitional Investor - Gilead Sciences, Inc.

Fund Profile
Filing Period:
Fund Name: Gilead Sciences, Inc.
Portfolio Value $1,648,747,919
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Arcus Biosciences Inc.
 RCUS 31,424,760 $968,825,351 58.76%
2.
Galapagos Nv
 GLPG 16,707,477 $500,157,715 30.34%
3.
Assembly Biosciences Inc.
 ASMB 4,977,089 $136,770,406 8.3%
4.
Kyverna Therapeutics Inc.
 KYTX 4,126,119 $36,763,720 2.23%
5.
Xilio Therapeutics Inc.
 XLO 650,389 $6,230,727 0.38%
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.